Nrf2 plays protective role during intermittent hypoxia-induced ferroptosis in rat liver (BRL-3A) cells

[1]  Q. Lin,et al.  Expression profiling and functional analysis of circular RNAs in vitro model of intermittent hypoxia-induced liver injury , 2022, Frontiers in Physiology.

[2]  Ke Peng,et al.  Dexmedetomidine Attenuates Ferroptosis-Mediated Renal Ischemia/Reperfusion Injury and Inflammation by Inhibiting ACSL4 via α2-AR , 2022, Frontiers in Pharmacology.

[3]  Wangliang Zhu,et al.  Ferroptosis-Specific Inhibitor Ferrostatin-1 Relieves H2O2-Induced Redox Imbalance in Primary Cardiomyocytes through the Nrf2/ARE Pathway , 2022, Disease markers.

[4]  Lijun Chen,et al.  Circular RNA Expression Profiles and Bioinformatic Analysis in Mouse Models of Obstructive Sleep Apnea-Induced Cardiac Injury: Novel Insights Into Pathogenesis , 2021, Frontiers in Cell and Developmental Biology.

[5]  Zhong-ping Zhang,et al.  Untargeted Metabolomic Profiling of Liver in a Chronic Intermittent Hypoxia Mouse Model , 2021, Frontiers in Physiology.

[6]  Yuanzheng Zhao,et al.  Ferrostatin-1 alleviates angiotensin II (Ang II)- induced inflammation and ferroptosis in astrocytes. , 2020, International immunopharmacology.

[7]  Zhongming Wu,et al.  Inhibition of ferroptosis by up-regulating Nrf2 delayed the progression of diabetic nephropathy. , 2020, Free radical biology & medicine.

[8]  Dan Chen,et al.  Nrf2 protects against seawater drowning-induced acute lung injury via inhibiting ferroptosis , 2020, Respiratory Research.

[9]  Q. Lin,et al.  The role of ferroptosis in chronic intermittent hypoxia-induced liver injury in rats , 2020, Sleep and Breathing.

[10]  N. Sata,et al.  Iron overload as a risk factor for hepatic ischemia‐reperfusion injury in liver transplantation: Potential role of ferroptosis , 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[11]  F. Gao,et al.  Ferroptosis as a target for protection against cardiomyopathy , 2019, Proceedings of the National Academy of Sciences.

[12]  J. Roh,et al.  Nrf2 inhibition reverses resistance to GPX4 inhibitor‐induced ferroptosis in head and neck cancer , 2018, Free radical biology & medicine.

[13]  F. García-Río,et al.  Obstructive sleep apnea and dyslipidemia: from animal models to clinical evidence , 2018, Sleep.

[14]  Hong Luo,et al.  Dysfunction of Nrf2-ARE Signaling Pathway: Potential Pathogenesis in the Development of Neurocognitive Impairment in Patients with Moderate to Severe Obstructive Sleep Apnea-Hypopnea Syndrome , 2018, Oxidative medicine and cellular longevity.

[15]  Xiaoyuan Chen,et al.  Emerging Strategies of Cancer Therapy Based on Ferroptosis , 2018, Advanced materials.

[16]  B. Mokhlesi,et al.  Obstructive Sleep Apnea and Diabetes: A State of the Art Review. , 2017, Chest.

[17]  L. Cai,et al.  Intermittent hypoxia-induced cardiomyopathy and its prevention by Nrf2 and metallothionein. , 2017, Free radical biology & medicine.

[18]  M. Rauh,et al.  Nrf2-Keap1 pathway promotes cell proliferation and diminishes ferroptosis , 2017, Oncogenesis.

[19]  R. Bordet,et al.  Ferroptosis, a newly characterized form of cell death in Parkinson's disease that is regulated by PKC , 2016, Neurobiology of Disease.

[20]  D. Tang,et al.  Activation of the p62‐Keap1‐NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells , 2016, Hepatology.

[21]  M. R. Lamprecht,et al.  Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death , 2012, Cell.

[22]  G. Musso,et al.  Obstructive Sleep Apnea–Hypopnea Syndrome and Nonalcoholic Fatty Liver Disease: Emerging Evidence and Mechanisms , 2012, Seminars in Liver Disease.